During the past decade, Rush-Copley Healthcare Center conducted 133 clinical trials. In the 10-year time frame, 133 clinical trials started and 62 clinical trials were completed, i.e. on average, 46.6% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 45 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rush-Copley Healthcare Center" #1 sponsor was "National Cancer Institute (NCI)" with 87 trials, followed by "SWOG Cancer Research Network" with 36 trials sponsored, "Alliance for Clinical Trials in Oncology" with 31 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "NRG Oncology" with 18 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rush-Copley Healthcare Center" #1 collaborator was "National Cancer Institute (NCI)" with 103 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Rush-Copley Healthcare Center" are "Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (7 trials). Many other conditions were trialed in "Rush-Copley Healthcare Center" in a lesser frequency.

Most popular intervention types in "Rush-Copley Healthcare Center" are "Drug" (145 trials), "Other" (120 trials), "Biological" (79 trials), "Procedure" (50 trials) and "Radiation" (20 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (55 trials), "Quality-of-Life Assessment" (51 trials), "Questionnaire Administration" (34 trials), "Biospecimen Collection" (29 trials) and "Computed Tomography" (27 trials). Other intervention names were less common.

The vast majority of trials in "Rush-Copley Healthcare Center" are 159 trials for "All" genders, 30 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Rush-Copley Healthcare Center". undefined are not yet recruiting, 63 are recruiting, 93 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Rush-Copley Healthcare Center, 4 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Rush-Copley Healthcare Center, 5 "Phase 1" clinical trials were conducted, 99 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".